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Overview
Broncholithiasis refers to the presence of calcified material 
that erodes into the lumen of the tracheobronchial tree or 
lung parenchyma, potentially causing inflammation and 
obstruction (1). Consequences from broncholithiasis range 
widely from being asymptomatic to life threatening such as 
recurrent pneumonias, hemoptysis, and bronchoesophageal 
fistula. Management varies depending upon several factors 
including patient symptoms, associated lung disease, 
and mobility of the broncholith within the airway, but 
typically involves either observation or intervention via 
bronchoscopy or thoracic surgery. This paper reviews the 
etiology, clinical presentation, radiologic appearance, and 
management of broncholithiasis.
Definition and etiology
The term broncholithiasis is the condition that arises when 
a broncholith causes airway irritation, obstruction, or 
erosion into adjacent structures (2). The vast majority of 
broncholiths are formed by the partial or complete erosion 
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of an adjacent calcified peribronchial lymph node into the 
airway lumen. Erosion of a broncholith into the airway 
is thought to result from the repeated physical contact of 
a calcified lymph node with an adjacent bronchus during 
normal respiratory motion (1). Nodal calcification in the 
thorax most often occurs from long-standing lymphadenitis 
related to fungal or mycobacterial infections, with 
Histoplasma capsulatum representing the most common 
causative organism in the United States. Less common 
infectious etiologies include tuberculosis, actinomycosis, 
coccidioidomycosis, and cryptococcosis (3). Due to airway 
anatomy and normal lymph node distribution, the most 
commonly affected bronchi are the proximal right middle 
lobe bronchus, the bronchus intermedius, and the origin of 
the anterior segment right upper lobe bronchus, in order of 
frequency (1,3-5). 
Other etiologies of broncholithiasis are less common. 
Broncholiths can arise as extrinsic calculi from aspirated 
foreign material (4), such as aspirated fragments of bone 
or foreign debris which calcifies in situ within the airway 
over time. Calcified cartilage rings in the airway wall can 
also extrude and become sequestered inside the lumen of 
the bronchus forming broncholiths. Calcified material 
from remote locations within the thorax, such as fragments 
of calcified pleural plaques, can migrate over time and 
eventually erode into a bronchus (6). Extremely rare cases 
of calcified endobronchial hamartomas and carcinoid 
tumors, primary ciliary dyskinesia-associated broncholiths, 
and silicosis-associated egg shell lymph node broncholiths 
have also been reported (6-8). 
Clinical presentation, symptoms, and 
radiographic findings
The severity and type of patients’ symptoms are typically 
related to the degree of bronchial inflammation, obstruction, 
or involvement of adjacent structures (Tables 1-3). Given 
that the most common symptom is chronic cough, most 
patients present in the outpatient setting (3). Cough 
associated with broncholithiasis can be dry or productive 
of mucous, purulence, or “gravel”. The latter symptom, 
termed lithoptysis,  occurs when fragments of the 
broncholith are expectorated. Symptoms or conditions 
that may necessitate inpatient care include pneumonia, 
hemoptysis, and the development of fistulae between the 
bronchi and mediastinal structures (1). 
While routine chest radiographs can reveal findings 
of hilar calcifications or parenchymal infiltrates (3), they 
lack the resolution to identify the causative broncholith 
(Figure 1A). On occasion, a broncholith cannot be identified 
even on diagnostic bronchoscopy due to partial erosion 
of the node into the airway, with a reported incidence 
Table 1 Summary of publications of clinical presentations and radiographic findings in broncholithiasis 
Publication Patients Etiology Clinical presentation Radiographic findings
Kennedy 
2007 (8)
28 Primary ciliary 
dyskinesia
Lithoptysis (n=5, 18%) Bronchiectasis (n=28, 100%)
Tsubochi 
2007 (9)
2 Fungal infection 
(aspergillosis and 
actinomycosis)
Hemoptysis (n=2, 100%) Consolidation (n=2, 100%), bronchiectasis (n=1, 
50%)
Ford  
2005 (10) 
9 Not specified Cough after drinking (n=8, 89%), 
dysphagia (n=1, 11%), lithoptysis (n=6, 
66%), recurrent pneumonia (n=6, 66%)
Esophageal radiocontrast studies showed fistula 
(n=9)
Kim  
2005 (11) 
9 Fungal infection 
(actinomycosis)
Cough (n=8, 89%), sputum production 
(n=8, 89%), hemoptysis (n=5, 55%)
Distal obstruction (n=8, 89%) atelectasis (n=2, 22%), 
central necrosis within consolidation (n=4, 44%), 
cavitary lesion (n=3, 33%), airway narrowing (n=2, 
22%), airway obstruction (n=7, 78%), bronchiectasis 
(n=4, 44%), pleural thickening (n=2, 22%)
Conces 
1991 (12)
15 Not specified Cough (n=13, 87%), hemoptysis (n=6, 
40%), chest pain (n=3, 20%), sputum 
production (n=3, 20%), fever (n=2, 
13%), lithoptysis (n=2, 13%), halitosis 
(n=1, 7%), wheezing (n=1, 7%)
Atelectasis (n=11, 73%), distal obstruction (n=4, 
27%), bronchiectasis (n=4, 27%), air trapping (n=1, 
7%)
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Table 2 Major series of bronchoscopic management of broncholithiasis
Publication Patients Procedures
Type of 
bronchoscopy
Outcomes Complications
Cerfolio 2008 (1) 50 38 Rigid 29 attempted, 29 removed (100%) None reported
Menivale 2005 (13) 4 4 Flexible 2 attempted, 2 removed (100%) None reported
Yi 2005 (14) 2 2 Flexible 2 attempted, 2 removed None reported
Olson 1999 (15) 95 95 (127 broncholiths 
identified)
Flexible and 
Rigid
71 attempted, 46 removed (65%) 
overall; 67% with rigid, 30% with 
flexible 
Hemorrhage (n=1, 1.4%) 
broncholith dislodgement 
(n=1, 1.4%)
Cole 1986 (16) 42 40 Flexible and 
Rigid
8 (19%) removed; attempts not 
reported; 75% with rigid
None reported
Dixon 1984 (3) 19 18 Flexible and 
Rigid
8 attempted, 4 removed (50%); (75%) 
with rigid
None reported
Trastek 1985 (17) 52 12 Unavailable 12 attempted, 8 removed; additional 40 
patients treated surgically
Unavailable
Moersch 1959 (18) 87 33 Unavailable 33 attempted; success rate unknown Unavailable
Table 3 Major series of surgical management of broncholithiasis
Publication Patients Etiology Type of surgery Complications
Hammoud 
2009 (19)
13 Fixed broncholiths, 
recurrent pneumonia 
and/or hemoptysis from 
histoplasmosis 
Lobectomy (n=7, 54%); Bilobectomy 
(n=5, 38%); transbronchial excision of 
LN (n=1; 8%)
Air leak (n=1, 7.7%); empyema (n=1, 
7.7%)
Cerfolio  
2008 (1)
5 BE fistula (n=2, 40%); fixed 
broncholith (n=3, 60%)
Thoracotomy with LN curettage and/or 
removal (n=5, 100%)
None reported
Potaris  
2000 (20)
47 Hemoptysis (n=21, 45%); 
recurrent pneumonia (n=11, 
23%); suspected BE fistula 
(n=5, 11%); suspected 
malignancy (n=6, 13%); 
failed bronchoscopy (n=4, 
9%)
Lobectomy (n=16, 34%); bilobectomy 
(n=4, 8.5%); segmentectomy 
(n=7, 15%); wedge resection 
(n=2, 4%); pneumonectomy (n=1, 
2%); broncholithectomy with 
pulmonary resection (n=30, 64%); 
broncholithectomy only (n=9, 19%); 
broncholithectomy with bronchoplasty 
(n=7; 15%); sleeve resection of left 
mainstem (n=1, 2%)
Intraop (n=6, 12.8%): PA laceration 
(n=4, 8.5%); esophageal laceration (n=1, 
2.1%); mainstem bronchus laceration 
(n=1, 2.1%); postop (n=16, 34%): 
hemothorax (n=2); empyema (n=2); 
wound dehiscence (n=1); PA thrombosis 
(n=1); lingua necrosis (n=1); respiratory 
insufficiency (n=3); confusion (n=2); 
prolonged air leak (n=2); pneumothorax 
(n=1); air atrial fibrillation (n=1);
Cole  
1986 (16)
25 Fixed broncholiths, 
symptoms after 
bronchoscopy, hemoptysis 
from histoplasmosis, 
aspergillosis, and 
tuberculosis
Thoracotomy (n=26, 100%); segmental 
resection (n=11, 42%), lobectomy 
(n=11, 42%), bronchotomy with 
broncholithectomy (n=3, 12%), 
tracheoesophageal fistula repair (n=1, 
4%)
None reported
BE, bronchoesophageal; LN, lymph node; PA, pulmonary artery.
ranging from 28–56% of cases (3,12,17,21). Computed 
tomography (CT) therefore plays a crucial role in the initial 
diagnosis, accurately identifying the specific location of 
the broncholith, the degree of endobronchial obstruction, 
and the presence of associated findings such as atelectasis, 
consolidation, bronchiectasis, air trapping, mucoid impaction 
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of a bronchus, or frank lung destruction (Figure 1B and 
Figure 2) CT imaging may also show other sequelae of long 
standing lymphadenitis or granulomatous disease, including 
mediastinal calcifications, nodules, and scarring. 
Management 
Conservative 
Management of broncholithiasis depends on several factors 
including patient symptoms, the size of the broncholith, its 
relationship with the airway wall, and its proximity to or 
involvement of adjacent thoracic structures. Indications for 
bronchoscopic or surgical intervention include symptoms 
related to intractable cough, recurrent pulmonary infections, 
symptomatic bronchiectasis, hemoptysis, and fistula 
formation. In general, conservative management in the form 
of observation is warranted in asymptomatic patients and 
those with minimal or non-recurring, non-life-threatening 
A B
Figure 1 Comparison of plain radiograph to computed tomography (CT) scan in the same patient with broncholithiasis. (A) Lateral chest 
radiograph demonstrates right middle lobe atelectasis (asterisk); (B) CT scan in sagittal reformat reveals the causative broncholith (arrow) 
obstructing the proximal right middle lobe bronchus.
A B
Figure 2 Common CT imaging findings in patients with broncholithiasis. (A) Axial chest CT image demonstrates a broncholith (arrow) in 
the left mainstem bronchus without parenchymal involvement; (B) axial chest CT image of a different patient demonstrates a broncholith 
(arrow) at the origin of the right middle lobe bronchus with associated bronchiectasis and parenchymal atrophy.
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symptoms. Also, patients with significant comorbidities or 
limited life span who may not tolerate invasive therapy are 
candidates for conservative therapy. Conservative measures 
to consider include cough suppression, bronchodilators, 
and empiric antimicrobial therapy. If sputum gram stain 
and culture or other laboratory testing identifies a specific 
infection, then antimicrobial therapy can be tailored 
accordingly. 
Bronchoscopy
Bronchoscopy has been described for both diagnostic 
and potentially therapeutic purposes in the symptomatic 
patient (22). When broncholithiasis is suspected based on 
clinical and radiographic findings, flexible bronchoscopy 
is often employed to confirm the diagnosis by direct 
visualization of a calcified stone in the airway (3,15). The 
typical broncholith appears as a yellow or white concretion, 
sometimes with areas of dark discoloration (Figure 3A). 
When tapped with forceps through the working channel 
of the bronchoscope, it has a hard texture and may be 
either mobile or fixed. The adjacent airway mucosa 
is often inflamed and friable with blood oozing when 
touched. Granulation tissue may also be present. When 
the broncholith cannot be identified, evidence of airway 
distortion or inflammatory obstruction is typically observed.
In addition to confirming the diagnosis, bronchoscopy 
can aspirate secretions for therapeutic purposes and obtain 
cultures which may guide antibiotic therapy. During 
bronchoscopy, the degree of broncholith mobility should 
be assessed, as this may dictate further management. It 
is, however, occasionally difficult to assess the degree of 
mobility as well as any involvement of important structures 
beyond the bronchial wall, such as pulmonary vasculature. 
This underscores the need for CT imaging with intravenous 
contrast prior to any attempt at bronchoscopic removal with 
attention directed at identifying major vascular structures in 
the vicinity of the broncholith. Saline irrigation and forceps 
manipulation during bronchoscopy have been described 
as methods to assess the degree of attachment (13,16) 
(Figure 3B). Use of topical lidocaine and epinephrine have 
been described to minimize bronchial wall bleeding during 
broncholith manipulation (23). 
The pathophysiology of broncholithiasis represents a 
distinct entity when compared to other forms of foreign 
bodies in the airways (19). As such, bronchoscopic 
management may differ from traditional forms of 
foreign body removal where extraction using flexible or 
rigid bronchoscopy is often feasible (17). Historically, 
bronchoscopic broncholithectomy was not recommended 
due to concern of complications including bleeding, 
displacement of the broncholith causing obstruction, or 
iatrogenic creation of a fistula. The role of therapeutic 
bronchoscopy in the context of broncholithiasis has evolved 
however to include select cases (2). Olson et al. reported on 
48 patients who underwent bronchoscopic removal with 
only a 4% complication rate (15). The authors determined 
that mobile broncholiths could be safely removed, as well 
A B
Figure 3 Bronchoscopic visualization of broncholiths. (A) Bronchoscopic visualization of broncholith in right mainstem bronchus (thick red arrow) 
with associated mucosal edema; (B) forceps extraction (thin red arrow) of broncholith (thick red arrow) during bronchoscopic intervention.
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as some partially-eroding broncholiths. In this series, there 
was a high risk of complications, particularly hemorrhage, 
when broncholiths were partially embedded in the bronchial 
wall (15). Cerfolio and colleagues reported their experience 
in 50 patients with broncholithiasis (1). The authors reached 
a similar conclusion that broncholiths which are mobile can 
be safely removed with bronchoscopy, whereas surgery is 
typically indicated for symptomatic patients not amenable 
to bronchoscopic treatment. In summary, retrospective 
studies support an initial attempt at bronchoscopic removal 
in cases where broncholiths are mobile or loosely attached 
to the bronchial wall. 
During bronchoscopy, if forceps extraction is not readily 
feasible, more investigational options are available to 
facilitate removal. The use of a balloon catheter has been 
described for removal of a partially eroded broncholith (14). 
With this technique, the balloon is inserted distal to 
the stone. The balloon is then inflated and pulled back 
in an attempt to dislodge the stone proximally. This 
technique mimics that where a closed forcep is passed 
beyond the broncholith, opened, and then retracted. Stone 
fragmentation which facilitates extraction using holmium-
yttrium aluminum garnet (Ho:YAG) (24) and neodymium-
doped yttrium aluminum garnet (Nd:YAG) (15,25) lasers 
has been reported. Bronchoscopic lithotripsy similar to 
that used in nephrolithiasis has also been reported (26). 
More recently, the use of a cryotherapy probe for 
broncholithectomy was described. Some have advocated 
the use of rigid bronchoscopy with larger working 
channels (1) to facilitate stone extraction, however, this 
modality is generally now reserved for very select cases 
in which flexible bronchoscopy has failed (15). Use of 
a pediatric bronchoscope has been described to reach 
endobronchial lesions in the distal airways (27) Lastly, the 
use of a covered self-expandable metallic stent has been 
described in a case in which the broncholith was associated 
with a bronchoesophageal fistula (28). In a separate but 
similar case, endoscopic placement of an esophageal 
stent was described for a poor surgical candidate with 
bronchoesophageal fistula (29).
In the patient presenting with hemoptysis as a complication 
of broncholithiasis, diagnostic bronchoscopy should be 
pursued to identify the location of bleeding and etiology 
of hemoptysis, if possible. The decision to proceed with 
observation versus broncholith removal, however, should 
be based on the frequency and quantity of hemoptysis 
coupled with the predicted ease of broncholith removal. 
There are published reports of massive hemoptysis caused 
by broncholithiasis (30); however, management of bleeding 
due to bronchoscopic removal of broncholiths has scarcely 
been described. Techniques that have been described for 
other etiologies of hemoptysis may be useful in these cases. 
Placement in the lateral decubitus position, with the affected 
side down, has been proposed, as has the use of selective 
mainstem bronchus intubation (31). Likewise, insertion 
of a balloon catheter adjacent to the endotracheal tube to 
tamponade the site of bleeding has been described (31). These 
should be regarded as temporizing measures while definitive 
therapy is planned. Flexible or rigid bronchoscopy with 
various methods of cautery may be of some use. The use of 
endobronchial hemostatic devices placed via bronchoscopy has 
been described but has yet to achieve widespread adoption (32). 
Bronchial artery embolization or thoracic surgery is required 
for definitive therapy (33,34).
In addition to hemorrhage, complications of bronchoscopic 
broncholithectomy include airway obstruction due to stone 
dislodgement, fistula creation, and damage to the bronchial 
wall (15,35). On occasion, attempts at stone extraction can 
result in inadvertent advancement of the broncholith with 
distal airway occlusion, necessitating further intervention (23). 
Cases involving embedded broncholiths may lead to formation 
of bronchomediastinal or bronchoesophageal fistulae when 
the stone is removed (28,36). Table 2 summarizes published 
series on bronchoscopic management of broncholithiasis. 
The highest reported success rates approach 100% for freely 
mobile broncholiths. The success rate of intervening on 
partially eroded or fixed broncholiths ranges from 0–48% 
(1,15). Bronchoscopic interventions for adherent broncholiths 
should only be attempted by experienced operators at 
specialized centers with appropriate interventional radiology 
and thoracic surgery expertise in case of serious complications. 
Moreover, in an otherwise healthy patient with significant 
distal lung destruction such as bronchiectasis or fistulization 
into an adjacent structure, high-risk bronchoscopic procedures 
should be avoided in deference of surgical intervention. 
Surgery
Surgical intervention is indicated for symptomatic 
patients without precluding comorbidities in whom 
therapeutic bronchoscopy is unable to relieve the airway 
obstruction. These patients often suffer from complications 
related to recurrent pneumonia, hemoptysis, substantial 
distal bronchiectasis or parenchymal destruction, or 
fistulae between the airway and mediastinal structures 
(Figure 4) (13). While there is current enthusiasm to 
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perform pulmonary surgery using minimally invasive 
approaches such as thoracoscopy or robotic technology, 
calcific fibrosis surrounding airway and pulmonary 
vasculature typically requires an open approach for the 
majority of these cases. Occasionally broncholiths can 
be removed through a small bronchotomy, followed by 
repair of the airway and takedown of any fistula if present, 
with interposition of pedicled soft tissue between the two 
structures, sparing normal pulmonary parenchyma (1). 
An anatomic pulmonary resection is usually required 
for  bronchol i ths  caus ing hemoptys i s  or  chronic 
obstruction with resultant end stage parenchymal damage 
(Figure 2B and Figure 4) Inflammation and dense fibrosis 
are frequently encountered during lobar hilar dissection, 
which makes branch pulmonary artery isolation and division 
risky. In these cases, initial placement of an umbilical tape 
proximally around the main pulmonary artery prior to 
lobar hilar dissection will allow rapid control of inadvertent 
bleeding. In cases where the lobar bronchus and pulmonary 
branch vessels are densely adherent, occluding the main 
pulmonary artery then amputating the lobar hilum for 
initial lung removal, usually allows safe separation of the 
airway and vessels followed by independent closure. Finally, 
parenchymal sparing sleeve resections for patients with 
significant involvement of the right upper lobe hilum can be 
utilized to avoid pneumonectomy. 
Table 3  summarizes the publications on surgical 
management of broncholithiasis. Potaris and colleagues 
reported their  exper ience  with  47 pat ients  wi th 
broncholithiasis requiring surgical intervention (20). The 
majority of patients were found to have right-sided lesions. 
Pulmonary resection was required in 64% of patients, while 
34% underwent broncholithectomy without pulmonary 
resection. We previously reported our experience in 49 
patients who underwent surgery for complications of 
histoplasmosis, 13 of which had broncholithiasis (19) and 
were not candidates for bronchoscopic removal due to 
broncholith adherence. Indications for surgery included either 
recurrent pneumonia or hemoptysis. Twelve of these patients 
underwent lobectomy or bilobectomy. In Cerfolio’s series, 
only 5 of 50 patients underwent surgery with thoracotomy 
and lymph node curettage, removal, or both (1). Potaris and 
colleagues documented the largest number of surgical cases 
and reports an intraoperative complication rate of 12.8% and 
a major postoperative complication rate of 15% (20). While 
the reported surgical morbidity appears high, to date there 
have been no operative deaths in published series. Given the 
potential for complications and the small but definite risk of 
recurrent broncholithiasis (20), surgery should be reserved 
for cases not amenable to conservative or bronchoscopic 
management. 
Conclusions
The management of broncholithiasis can be challenging 
and should be individualized for symptomatic patients. A 
A B
Figure 4 Advanced complications of broncholithiasis that required surgery. (A) Axial CT image of an otherwise healthy patient with several 
calcified lymph nodes surrounding the distal bronchus intermedius (arrow) with complete obstruction of the right middle lobe airway 
and secondary bronchiectasis and pneumonitis that was treated with thoracotomy and bilobectomy; (B) a separate case demonstrating a 
bronchoesophageal fistula (arrow) seen on gastrografin esophagram that developed after surgical removal of a broncholith in the bronchus 
intermedius. This case required a second thoracotomy with esophageal repair. 
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multidisciplinary approach with assessment by thoracic 
radiologists, interventional pulmonologists, and thoracic 
surgeons prior to implementing any treatment strategy is 
usually optimal for patient care. In cases of mobile or loosely 
attached broncholiths, therapeutic bronchoscopy is often 
effective with minimal risks. Bronchoscopic intervention 
in cases of partially eroded broncholiths does present risks 
of hemorrhage, broncholith dislodgement, and fistula 
formation, but can be considered by experienced operators 
at specialized centers capable of managing potential 
complications. In patients with acceptable operative risk 
levels, surgery remains the mainstay of treatment in cases 
with significant distal parenchymal destruction, severe 
hemoptysis, or where bronchoscopic intervention failed.
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